financetom
Business
financetom
/
Business
/
India is leading the charge on tackling climate challenge, says London deputy mayor
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India is leading the charge on tackling climate challenge, says London deputy mayor
Mar 20, 2023 3:26 PM

London's Deputy Mayor for Business Rajesh Agarwal on Monday, spoke about the immense opportunities for collaboration between the UK and India as progress continues on the much-awaited Indo-UK free trade agreement (FTA).

Share Market Live

NSE

Speaking to CNBC-TV18, Agarwal highlighted fintech and renewable energy as two key areas of interest for London companies seeking to expand into India, citing India's leadership in tackling the climate challenge as well as its rapidly-growing tech ecosystem.

Agarwal pointed out that climate technology is an evident area in which India is making significant advancements and taking the lead on several projects to address the climate problem, just as London and the UK are doing.

"India is doing a huge amount on climate technology and is leading the charge on some of the initiatives around tackling the climate challenge as is London and the UK."

However, according to Agarwal, the true deal is in the technology. He noted that the third-largest tech ecosystem in the world is located in London, where it is very quickly expanding. However, India is also a significant centre for technology, with a lot of activity happening around start ups, scale ups companies.

"But tech is the real price. There's very fast growing tech ecosystem in London, and is the third largest tech ecosystem in the world. And India is a huge Center for Technology, a lot of activity happening around start ups, scale ups companies."

Watch video for full interview.

First Published:Mar 20, 2023 11:26 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--RH Guides For FY 2024 Revenue Growth of 5%-7%; Sees Q3 Revenue Growth of 7%-9%
--RH Guides For FY 2024 Revenue Growth of 5%-7%; Sees Q3 Revenue Growth of 7%-9%
Sep 12, 2024
04:11 PM EDT, 09/12/2024 (MT Newswires) -- Price: 299.00, Change: +42.23, Percent Change: +16.45 ...
Mission Produce Insider Sold Shares Worth $685,447, According to a Recent SEC Filing
Mission Produce Insider Sold Shares Worth $685,447, According to a Recent SEC Filing
Sep 12, 2024
05:13 PM EDT, 09/12/2024 (MT Newswires) -- Luis A Gonzalez, 10% Owner, Director, on September 12, 2024, sold 51,615 shares in Mission Produce ( AVO ) for $685,447. Following the Form 4 filing with the SEC, Gonzalez has control over a total of 8,278,037 shares of the company, with 32,423 shares held directly and 8,245,614 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1802974/000182588524000024/xslF345X05/wk-form4_1726175264.xml...
Adobe forecasts downbeat quarterly earnings on cautious tech spending
Adobe forecasts downbeat quarterly earnings on cautious tech spending
Sep 12, 2024
Sept 12 (Reuters) - Photoshop maker Adobe forecast fourth-quarter earnings below analysts' estimates on Thursday, signaling stiff competition and soft demand for its AI-integrated editing tools amid challenging economic conditions. Shares of the company fell 9.2% in extended trading. High interest rates and a tough economy have led enterprises and individuals to focus on cutting costs, putting pressure on Adobe's...
BioNexus Gene Lab, Chenzhen Rongguang Health Group Partner to Expand Cancer Screening
BioNexus Gene Lab, Chenzhen Rongguang Health Group Partner to Expand Cancer Screening
Sep 12, 2024
01:42 PM EDT, 09/12/2024 (MT Newswires) -- BioNexus Gene Lab ( BGLC ) plans to partner with Chenzhen Rongguang Health Group to expand cancer screening and diagnostic tools in Southeast Asia and China. The collaboration includes research and development of exosome therapy and regenerative medicine, BioNexus said Thursday in a statement. Price: 0.49, Change: +0.14, Percent Change: +38.78 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved